Better Therapeutics, Inc. (NASDAQ:BTTX – Get Rating) insider Frank Karbe acquired 242,424 shares of the business’s stock in a transaction on Monday, April 10th. The stock was acquired at an average cost of $0.82 per share, for a total transaction of $198,787.68. Following the transaction, the insider now directly owns 292,424 shares in the company, […]
Form 10-K Better Therapeutics, For: Dec 31 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Advanced preparations for potential commercial launch of BT-001 in U.S. in mid-2023
Reported positive topline results from exploratory trial for fatty liver disease
Announced restructuring and. | March 30, 2023